Cyclophosphamide, known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system.
| FactSnippet No. 736,412 |
Cyclophosphamide, known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system.
| FactSnippet No. 736,412 |
Cyclophosphamide is in the alkylating agent and nitrogen mustard family of medications.
| FactSnippet No. 736,413 |
Cyclophosphamide was approved for medical use in the United States in 1959.
| FactSnippet No. 736,414 |
Cyclophosphamide is used to treat minimal change disease, severe rheumatoid arthritis, granulomatosis with polyangiitis, Goodpasture syndrome and multiple sclerosis.
| FactSnippet No. 736,415 |
Cyclophosphamide, used in combination with thalidomide or lenalidomide and dexamethasone has documented efficacy as an off-label treatment of AL amyloidosis.
| FactSnippet No. 736,416 |
Cyclophosphamide is a pregnancy category D drug and causes birth defects.
| FactSnippet No. 736,417 |
Cyclophosphamide has been found to significantly increase the risk of premature menopause in females and of infertility in males and females, the likelihood of which increases with cumulative drug dose and increasing patient age.
| FactSnippet No. 736,418 |
Cyclophosphamide-induced leukemia will often involve complex cytogenetics, which carries a worse prognosis than de novo AML.
| FactSnippet No. 736,419 |
Cyclophosphamide metabolites are primarily excreted in the urine unchanged, and drug dosing should be appropriately adjusted in the setting of renal dysfunction.
| FactSnippet No. 736,420 |
Cyclophosphamide has relatively little typical chemotherapy toxicity as ALDHs are present in relatively large concentrations in bone marrow stem cells, liver and intestinal epithelium.
| FactSnippet No. 736,421 |